Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Richard Onalo, FCPaed, Peter Cooper, FCPaed, Antoinette Cilliers, FCPaed, Uche Nnebe-Agumadu, FCPaed, Oluseyi Oniyangi, FCPaed, Damilare Oladimeji, MSc Statistics, Claudia R. Morris, MD

Blood (2019) 134 (Supplement_1): 613.

https://doi.org/10.1182/blood-2019-122510

Published: 2019

Journal Articles

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Hussain I Rangoonwala, MBBS, Jonathan Gootee, MD, Peter T. Silberstein, MD

Blood (2019) 134 (Supplement_1): 3840.

https://doi.org/10.1182/blood-2019-131233

Published: 2019

Journal Articles

Cellular and Molecular Characterization of Breast Cancer Chemotherapy-Related B Cell Lymphomas

Madeline Rodriguez Valentin, PhD, Darwing Rivas, BSc, Vesna Jurecic, BSc, Alain Diaz, PhD, Richard Riley, PhD, Daniela Frasca, PhD, Roland Jurecic, PhD

Blood (2019) 134 (Supplement_1): 5241.

https://doi.org/10.1182/blood-2019-127252

Published: 2019

Journal Articles

Epidemiology and Survivorship of Anaplastic Large Cell Lymphoma

Janani Baskaran, MD, Jonathan Gootee, MD, Peter T. Silberstein, MD

Blood (2018) 132 (Supplement 1): 2905.

https://doi.org/10.1182/blood-2018-99-120318

Published: 2018

Journal Articles

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Mahek Garg, Karina Raimundo, Anisha Patel, Richard H Ko

Blood (2018) 132 (Supplement 1): 2234.

https://doi.org/10.1182/blood-2018-99-116989

Published: 2018

Journal Articles

Adjuvant Chemotherapy Administration and Survival Outcomes in Lymphoma Survivors with Common Solid Tumors: A Population-Based Study

Mengyang Di, MD PhD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 621.

https://doi.org/10.1182/blood-2018-99-114250

Published: 2018

Journal Articles

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

Ryan B. Sinit, David M. Aboulafia, MD, Russell K. Dorer, MD PhD

Blood (2018) 132 (Supplement 1): 5340.

https://doi.org/10.1182/blood-2018-99-110278

Published: 2018

Journal Articles

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Mohamed Abd el mohsen, Maha Saber, Amira Adly, Eman Ismail, Omar Elalfy, MD, Elghamry Islam, Fatma Ibrahim, Mohsen Saleh Elalfy, MD

Blood (2018) 132 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2018-99-115186

Published: 2018

Journal Articles

Long Term Follow up after Adoptive Transfer of CD19-Specific CAR + T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell Transplantation (HSCT)

Blood (2017) 130 (Supplement 1): 2059.

https://doi.org/10.1182/blood.V130.Suppl_1.2059.2059

Published: 2017

Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4073.

https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073

Published: 2017

Journal Articles

Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma

Rayne H. Rouce, MD, Birju Mehta, Sandhya Sharma, Serena Kimi Perna, MD, Benjamin Shin, Vicky Torrano, Fnu Spoorthi, Natalia Lapteva, PhD, Catherine M. Bollard, MD, Adrian P. Gee, PhD, Carlos A. Ramos, MD, Shannon Inman, Karen L. Hodgkin, Kurt C. Gunter, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD

Blood (2016) 128 (22): 2990.

https://doi.org/10.1182/blood.V128.22.2990.2990

Published: 2016

Journal Articles

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Jonathan Allen Webster, MD, Anna Ferguson, BSN, RN, Christopher Gocke, MD, Richard J Jones, MD, Hyam Levitsky, MD, B. Douglas Smith, MD

Blood (2016) 128 (22): 3088.

https://doi.org/10.1182/blood.V128.22.3088.3088

Published: 2016

Journal Articles

Inhibition of CML Stem Cells with an Alkaloid That Reduces β-Catenin

Shawnya J. Michaels, MS,MBA, Ngoc DeSouza, PhDCandidate, Yi Shan, MD, Shaoguang Li, MD PhD, Saira Bates, MBA

Blood (2016) 128 (22): 1882.

https://doi.org/10.1182/blood.V128.22.1882.1882

Published: 2016

Journal Articles

The Prognostic Value for Survival of Patient-Reported Outcomes in Hematological Malignancies: A Systematic Review

Avrita Campinha-Bacote, BS MPH, Peter C Trask, Fabio Efficace, PhD

Blood (2016) 128 (22): 4793.

https://doi.org/10.1182/blood.V128.22.4793.4793

Published: 2016

Journal Articles

Synchronous Hodgkin's Lymphoma and Seminoma, a Rare Co-Existence and an Important Lesson

Prabhsimranjot Singh, MBBS, Sudhamshi Toom, MBBS, Makardhwaj S Shrivastava, MBBS, Jason Shaw, MD, David A Silver, MD FACS, Jasminka Balderacchi, MD, Jay S. Lipshitz, MD

Blood (2016) 128 (22): 5318.

https://doi.org/10.1182/blood.V128.22.5318.5318

Published: 2016

Journal Articles

Establishing a Role for Asthma Management As Adjuvant Therapy for Vaso-Occlusive Crisis: Pulmonary Risk Stratification and Proposed Interventions

Lorraine Elise Canham, MD BS, Taumoha Ghosh, MD, Matthew Grant, MD BS, Ashley T. Munchel, MD, Regina A. Macatangay, MD

Blood (2016) 128 (22): 4866.

https://doi.org/10.1182/blood.V128.22.4866.4866

Published: 2016

Journal Articles

Upregulation of Vav3 Is Required for Leukemogenesis By BCR-ABL through Polycomb Repression Complex Dependent De-Repression of the Cdkn2a Locus

Megha Desai, PhD, Kyung-Hee Chang, PhD, E. David Muench, BS, Anjelika Gasilina, Ashley Wellendorf, Xose R Bustelo, H. Leighton Grimes, PhD, Nicolas Nassar, PhD, Jose A Cancelas, MD PhD

Blood (2015) 126 (23): 3661.

https://doi.org/10.1182/blood.V126.23.3661.3661

Published: 2015

Journal Articles

Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia

Kyle Blaine Russell, Brandon P Theall, Lisandra Hernandez, Hannah M Wavering, Vesna Jurecic, Samita Andreansky, PhD, Robert B. Levy, PhD, Roland Jurecic, PhD

Blood (2015) 126 (23): 3611.

https://doi.org/10.1182/blood.V126.23.3611.3611

Published: 2015

Journal Articles

Loss of the TLE4 AML Tumor Suppressor Gene Contributes to Leukemic Cell Proliferation, Differentiation Arrest, and Chemotherapy Resistance through a COX-Dependent Inflammatory Pathway

Thomas H Shin, David A Sweetser, MD,PhD

Blood (2015) 126 (23): 1241.

https://doi.org/10.1182/blood.V126.23.1241.1241

Published: 2015

Journal Articles

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Ann Leen, PhD, Ifigeneia Tzannou, MD, Munu Bilgi, Hao Liu, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD, Rammurti T Kamble, MD, Carlos A. Ramos, MD, Bambi Grilley, RPh, Adrian P. Gee, PhD, Catherine M. Bollard, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, George Carrum, MD

Blood (2015) 126 (23): 186.

https://doi.org/10.1182/blood.V126.23.186.186

Published: 2015

NARROW

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Cellular and Molecular Characterization of Breast Cancer Chemotherapy-Related B Cell Lymphomas

Epidemiology and Survivorship of Anaplastic Large Cell Lymphoma

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Adjuvant Chemotherapy Administration and Survival Outcomes in Lymphoma Survivors with Common Solid Tumors: A Population-Based Study

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Long Term Follow up after Adoptive Transfer of CD19-Specific CAR + T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell Transplantation (HSCT)

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Inhibition of CML Stem Cells with an Alkaloid That Reduces β-Catenin

The Prognostic Value for Survival of Patient-Reported Outcomes in Hematological Malignancies: A Systematic Review

Synchronous Hodgkin's Lymphoma and Seminoma, a Rare Co-Existence and an Important Lesson

Establishing a Role for Asthma Management As Adjuvant Therapy for Vaso-Occlusive Crisis: Pulmonary Risk Stratification and Proposed Interventions

Upregulation of Vav3 Is Required for Leukemogenesis By BCR-ABL through Polycomb Repression Complex Dependent De-Repression of the Cdkn2a Locus

Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia

Loss of the TLE4 AML Tumor Suppressor Gene Contributes to Leukemic Cell Proliferation, Differentiation Arrest, and Chemotherapy Resistance through a COX-Dependent Inflammatory Pathway

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only